SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000926617-21-000029
Filing Date
2021-03-26
Accepted
2021-03-26 09:26:59
Documents
3
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A awh-20210325x8ka.htm 8-K/A 44083
2 EX-99.1 awh-20210325xex99_1.htm EX-99.1 254351
3 GRAPHIC awh-20210325xex99_1g001.jpg GRAPHIC 135062
  Complete submission text file 0000926617-21-000029.txt   486014
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34810 | Film No.: 21775021
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences